Cargando…
COVID-19 Diagnosis: Current and Future Techniques
COVID-19 pandemic continues to be a global threat, affecting more than 200 countries/territories at both human and economic level. This necessitates the rapid development of highly reliable diagnostic methods in order to effectively and accurately diagnose the pathology to prevent the spread of COVI...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585557/ https://www.ncbi.nlm.nih.gov/pubmed/34774862 http://dx.doi.org/10.1016/j.ijbiomac.2021.11.016 |
_version_ | 1784597716068728832 |
---|---|
author | Sharma, Aarjoo Balda, Sanjeev Apreja, Mansi Kataria, Kirti Capalash, Neena Sharma, Prince |
author_facet | Sharma, Aarjoo Balda, Sanjeev Apreja, Mansi Kataria, Kirti Capalash, Neena Sharma, Prince |
author_sort | Sharma, Aarjoo |
collection | PubMed |
description | COVID-19 pandemic continues to be a global threat, affecting more than 200 countries/territories at both human and economic level. This necessitates the rapid development of highly reliable diagnostic methods in order to effectively and accurately diagnose the pathology to prevent the spread of COVID-19. Currently, RT-PCR is the most widely used method worldwide for SARS-CoV-2 detection. Serological assays are being used for sero-surveys of SARS-CoV-2 antibody prevalence in the community. Radiology imaging has been useful in the clinical diagnosis of COVID-19. These methods have their own limitations and there are continued efforts to develop easier, economic, highly sensitive and specific, point-of-care methods. Reverse transcription-loop mediated isothermal amplification (RT-LAMP), nucleic acid sequence-based amplification (NASBA), CRISPR-Cas-based detection, and digital PCR are such techniques being employed in research laboratories, with many awaiting diagnostic approval from competent authorities. This review highlights the rapidly expanding array of existing and in-development diagnostic tests/strategies that may be used to diagnose SARS-CoV-2 infection in both clinical and research settings. |
format | Online Article Text |
id | pubmed-8585557 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Published by Elsevier B.V. |
record_format | MEDLINE/PubMed |
spelling | pubmed-85855572021-11-12 COVID-19 Diagnosis: Current and Future Techniques Sharma, Aarjoo Balda, Sanjeev Apreja, Mansi Kataria, Kirti Capalash, Neena Sharma, Prince Int J Biol Macromol Review COVID-19 pandemic continues to be a global threat, affecting more than 200 countries/territories at both human and economic level. This necessitates the rapid development of highly reliable diagnostic methods in order to effectively and accurately diagnose the pathology to prevent the spread of COVID-19. Currently, RT-PCR is the most widely used method worldwide for SARS-CoV-2 detection. Serological assays are being used for sero-surveys of SARS-CoV-2 antibody prevalence in the community. Radiology imaging has been useful in the clinical diagnosis of COVID-19. These methods have their own limitations and there are continued efforts to develop easier, economic, highly sensitive and specific, point-of-care methods. Reverse transcription-loop mediated isothermal amplification (RT-LAMP), nucleic acid sequence-based amplification (NASBA), CRISPR-Cas-based detection, and digital PCR are such techniques being employed in research laboratories, with many awaiting diagnostic approval from competent authorities. This review highlights the rapidly expanding array of existing and in-development diagnostic tests/strategies that may be used to diagnose SARS-CoV-2 infection in both clinical and research settings. Published by Elsevier B.V. 2021-12-15 2021-11-12 /pmc/articles/PMC8585557/ /pubmed/34774862 http://dx.doi.org/10.1016/j.ijbiomac.2021.11.016 Text en © 2021 Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Review Sharma, Aarjoo Balda, Sanjeev Apreja, Mansi Kataria, Kirti Capalash, Neena Sharma, Prince COVID-19 Diagnosis: Current and Future Techniques |
title | COVID-19 Diagnosis: Current and Future Techniques |
title_full | COVID-19 Diagnosis: Current and Future Techniques |
title_fullStr | COVID-19 Diagnosis: Current and Future Techniques |
title_full_unstemmed | COVID-19 Diagnosis: Current and Future Techniques |
title_short | COVID-19 Diagnosis: Current and Future Techniques |
title_sort | covid-19 diagnosis: current and future techniques |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8585557/ https://www.ncbi.nlm.nih.gov/pubmed/34774862 http://dx.doi.org/10.1016/j.ijbiomac.2021.11.016 |
work_keys_str_mv | AT sharmaaarjoo covid19diagnosiscurrentandfuturetechniques AT baldasanjeev covid19diagnosiscurrentandfuturetechniques AT aprejamansi covid19diagnosiscurrentandfuturetechniques AT katariakirti covid19diagnosiscurrentandfuturetechniques AT capalashneena covid19diagnosiscurrentandfuturetechniques AT sharmaprince covid19diagnosiscurrentandfuturetechniques |